These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 18682167

  • 1. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B, Sánchez-Carazo JL, Pérez-Ferriols A, Laguna C, Oliver V, Alegre V.
    Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A, Esposito M, Costanzo A, Chimenti S.
    Am J Clin Dermatol; 2009 Sep; 10(5):319-24. PubMed ID: 19658444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Long-term safety and efficacy of etanercept in the treatment of psoriasis].
    Zaragoza V, Pérez A, Sánchez JL, Oliver V, Martínez L, Alegre V.
    Actas Dermosifiliogr; 2010 Sep; 101(1):47-53. PubMed ID: 20109392
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Etanercept in the treatment and retreatment of psoriasis in daily clinical practice.
    Barrera MV, Habicheyn S, Mendiola MV, Herrera Ceballos E.
    Eur J Dermatol; 2008 Sep; 18(6):683-7. PubMed ID: 19049936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S.
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Etanercept: efficacy and safety.
    Jiménez-Puya R, Gómez-García F, Amorrich-Campos V, Moreno-Giménez JC.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):402-5. PubMed ID: 19210697
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F.
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
    Landells I, Paller AS, Pariser D, Kricorian G, Foehl J, Molta C, Freundlich B.
    Eur J Dermatol; 2010 Aug; 20(3):323-8. PubMed ID: 20185386
    [Abstract] [Full Text] [Related]

  • 20. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L, Etanercept Psoriasis Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.